Cargando…

Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review

Growing research has focused on obesity as a prognostic factor during therapy with immune-checkpoint inhibitors (ICIs). The role of body-mass index (BMI) in predicting response and toxicity to ICIs is not clear, as studies have shown inconsistent results and significant interpretation biases. We per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indini, Alice, Rijavec, Erika, Ghidini, Michele, Tomasello, Gianluca, Cattaneo, Monica, Barbin, Francesca, Bareggi, Claudia, Galassi, Barbara, Gambini, Donatella, Grossi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961496/ https://www.ncbi.nlm.nih.gov/pubmed/33807855 http://dx.doi.org/10.3390/ijms22052628

Ejemplares similares

The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score
por: Ghidini, Michele, et al.
Publicado: (2021)

Coronavirus infection and immune system: An insight of COVID-19 in cancer patients
por: Indini, Alice, et al.
Publicado: (2020)

1765P Developing a risk assessment score for cancer patients during the COVID-19 pandemic
por: Indini, A., et al.
Publicado: (2020)

1689P The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists
por: Ghidini, M., et al.
Publicado: (2020)

1696P Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study
por: Grossi, F., et al.
Publicado: (2020)

Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022)

Impact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis
por: Indini, Alice, et al.
Publicado: (2020)

Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts
por: Indini, Alice, et al.
Publicado: (2020)

Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
por: Indini, Alice, et al.
Publicado: (2020)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

Novel treatment strategies for early-stage lung cancer: the oncologist’s perspective
por: Indini, Alice, et al.
Publicado: (2020)

Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors
por: Indini, Alice, et al.
Publicado: (2021)

Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021)

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review
por: Barbin, Francesca, et al.
Publicado: (2022)

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022)

Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies
por: Petrelli, Fausto, et al.
Publicado: (2022)

Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
por: Rijavec, Erika, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients with Classic Kaposi’s Sarcoma
por: Indini, Alice, et al.
Publicado: (2021)

Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2020)

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
por: Gambini, Donatella, et al.
Publicado: (2022)

Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic
por: Zaniboni, Alberto, et al.
Publicado: (2020)

High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks
por: Balendra, Vyshnavy, et al.
Publicado: (2023)

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
por: Pagni, Fabio, et al.
Publicado: (2019)

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study
por: Rutkowski, Piotr, et al.
Publicado: (2020)

Predictors of Lymph Node Metastasis in T1 Colorectal Cancer in Young Patients: Results from a National Cancer Registry
por: Ramai, Daryl, et al.
Publicado: (2021)

Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2019)

Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2020)

Everolimus treatment in advanced solid tumors: a personal view
por: Pusceddu, Sara, et al.
Publicado: (2015)

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options
por: Grizzi, Giulia, et al.
Publicado: (2020)

Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
por: Ghidini, Michele, et al.
Publicado: (2019)

Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
por: Indini, Alice, et al.
Publicado: (2019)

IDH Signalling Pathway in Cholangiocarcinoma: From Biological Rationale to Therapeutic Targeting
por: Salati, Massimiliano, et al.
Publicado: (2020)

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
por: Trevisani, Francesco, et al.
Publicado: (2022)

Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
por: Indini, Alice, et al.
Publicado: (2021)

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021)

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
por: Indini, Alice, et al.
Publicado: (2021)

Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
por: Tomasello, G., et al.
Publicado: (2022)

Cancer Mechanisms and Emerging Therapies
por: Gulei, Diana, et al.
Publicado: (2021)

Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature
por: Franzi, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55nhhi84cnge1sgijkpnv8di2p